Trianni mouse model tapped for HIV vaccine research

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/unoL)
(Image: Getty/unoL)

Related tags: License, Hiv, Research, CAR-T, Monoclonal antibodies

Trianni and San Diego Biomedical Research Institute enter license agreement for the use of the Trianni Mouse in HIV vaccine research.

Trianni Mouse, a transgenic mouse R&D platform for the discovery of fully human monoclonal antibodies (mAb) will be used by San Diego Biomedical Research Institute as the research institute to support its HIV vaccine research efforts.

Trianni CEO Matthias Wabl explained that the human antibody platform is powered by a mouse that when injected with a therapy target, produces human antibodies. Depending on the terms of the license, the mice are delivered to the licensee that isolates from the mice antibodies that are drug candidates, he told us

Joanna Davies, president and CEO at SDBRI, said in a statement, “We are extremely hopeful that the Trianni Mouse will accelerate our progress towards developing a successful HIV vaccine.”

The Trianni Mouse model has been used in license agreements to advance drug discovery. Juno Therapeutics​ entered an agreement with Trianni in 2017 to use the mouse model to identify full-human binders for conversion to chimeric antigen receptors (CAR) as part of its engineered T cell programs.

No financial details of the agreement were disclosed. 

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers

Follow us

Products

View more

Webinars